Summary

Market Overview:

The global tuberculosis diagnostics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028.

Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient’s sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

Tuberculosis Diagnostics Market Trends:
The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease stage, test type, and end-user.

Breakup by Disease Stage:

Latent TB
Active TB

Breakup by Test Type:

Radiographic Test
Laboratory Test
Smear Microscopy
Culture-based Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Others

Breakup by End-User:

Hospitals and Clinics
Diagnostics and Research Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMérieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:
How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
What is the breakup of the market based on the disease stage?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global tuberculosis diagnostics market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Tuberculosis Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Stage
6.1 Latent TB
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Active TB
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Test Type
7.1 Radiographic Test
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Laboratory Test
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Smear Microscopy
7.2.2.2 Culture-based Test
7.2.3 Market Forecast
7.3 Nucleic Acid Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cytokine Detection Test
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Drug Resistance Test
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End-User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostics and Research Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alere Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Becton Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BioMérieux
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cepheid Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Epistem Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Roche Holding AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Hain Lifescience GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Hologic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN GmbH
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Siemens
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2022
Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2022
Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2022
Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Tuberculosis Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2023-2028
Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
Table 7: Global: Tuberculosis Diagnostics Market: Key Players